Market Tracker

09/15 6:05pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
36.40 -0.13 / -0.36%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
36.40 0.00 / 0.00%
 
Volume: 4.0K

Today’s Trading

Previous close36.53
Today’s open36.04
Day’s range36.01 - 36.60
Volume1,054,118
Average volume (3 months)796,687
Market cap$2.7B
Dividend yield--
Data as of 3:59pm ET, 09/15/2014

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-20.65%
Earnings growth (next 5 years)+15.22%
Revenue growth (last year)+26.92%
P/E ratio16.2
Price/Sales3.79
Price/Book3.73

Competitors

 Today’s
change
Today’s
% change
--Cosmo Pharmaceutical...-11.95-6.38%
MNKDMannkind Corp-0.30-4.49%
WXWuXi Pharmatech (Cay...-0.57-1.59%
ACADACADIA Pharmaceutica...-1.45-5.13%
Data as of 4:03pm ET, 09/15/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts